These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7902877)
1. P-glycoprotein expression in bladder cancer. Park J; Shinohara N; Liebert M; Noto L; Flint A; Grossman HB J Urol; 1994 Jan; 151(1):43-6. PubMed ID: 7902877 [TBL] [Abstract][Full Text] [Related]
2. [Intravesical instillation of combined adriamycin and verapamil in preventing recurrence of superficial bladder tumor]. Liu NB Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):330-2. PubMed ID: 7906217 [TBL] [Abstract][Full Text] [Related]
3. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy. Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of multiple drug resistance in human bladder cancer cell lines. Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862 [TBL] [Abstract][Full Text] [Related]
5. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. Dalton WS; Grogan TM; Meltzer PS; Scheper RJ; Durie BG; Taylor CW; Miller TP; Salmon SE J Clin Oncol; 1989 Apr; 7(4):415-24. PubMed ID: 2564428 [TBL] [Abstract][Full Text] [Related]
6. The role of P-glycoprotein in drug-resistant hematologic malignancies. Dalton WS; Grogan TM; Miller TP Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717 [No Abstract] [Full Text] [Related]
7. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of P-glycoprotein in the rat urinary bladder and the effect of verapamil on intravesical chemotherapy. Hashimoto H; Tokumitsu M; Saga Y; Okuyama M; Yachiku S Int J Urol; 2001 Mar; 8(3):118-23. PubMed ID: 11260336 [TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. Miller TP; Grogan TM; Dalton WS; Spier CM; Scheper RJ; Salmon SE J Clin Oncol; 1991 Jan; 9(1):17-24. PubMed ID: 1670642 [TBL] [Abstract][Full Text] [Related]
11. Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study. Ohi Y; Ohmori H; Shirahama T; Kawahara M; Matsumura Y; Tsushima T; Ohashi Y Cancer Chemother Pharmacol; 1992; 30 Suppl():S50-4. PubMed ID: 1394818 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of functional P-glycoprotein in rat hepatoma cells. Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826 [TBL] [Abstract][Full Text] [Related]
13. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study. Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915 [TBL] [Abstract][Full Text] [Related]
14. Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells. Lai T; Collins CM; Hall P; Morgan AP; Smith PJ; Stonebridge BR; Symes MO Eur J Cancer; 1993; 29A(3):378-83. PubMed ID: 8104443 [TBL] [Abstract][Full Text] [Related]
15. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867 [TBL] [Abstract][Full Text] [Related]
17. Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial. Tsushima T; Ohmori H; Ohi Y; Shirahama T; Kawahara M; Matsumura Y; Ohashi Y Cancer Chemother Pharmacol; 1994; 35 Suppl():S69-75. PubMed ID: 7994791 [TBL] [Abstract][Full Text] [Related]
18. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents. Jachez B; Loor F Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. Nakagawa M; Emoto A; Nasu N; Hanada T; Kuwano M; Cole SP; Nomura Y J Urol; 1997 Apr; 157(4):1260-4; discussion 1264-5. PubMed ID: 9120915 [TBL] [Abstract][Full Text] [Related]
20. Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells. Simpson WG; Tseng MT; Anderson KC; Harty JI J Urol; 1984 Sep; 132(3):574-6. PubMed ID: 6433043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]